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1. Introduction 
The world market for herbal medicines is around US$ 40 billion, whereas in Brazil it is 
estimated to be around US$ 1 billion. Data from the World Health Organization (WHO) 
shows that more than a half of the world population makes use of some type of medicinal 
herb searching for relief for painful or unpleasant symptoms. From that total at least 30% are 
provided by medical prescription (WHO, 1978). 
The application of traditional or popular knowledge about the use of healing plants, in the 
development of herbal drugs proves to be a fairly consequent and consistent strategy, as it 
can generate employment and income from the participation of the organized community in 
the process of development, production and insertion of the so developed product in the 
pharmaceutical market. It still may be appropriate from an ecological standpoint, when the 
botanical raw material for the production of this herbal medicine is obtained from 
specimens grown in deforested areas. When a project with this design is originated and 
developed in the scope of Pharmaceutical Sciences it is called an Ethnopharmaceutical study 
(BARBOSA, 1998). 
Since 2006, the Popular Phytotherapy became a therapeutical option supported by the 
Brazilian government, through the National Policy on Integrative and Complementary 
Practices (BRAZIL, 2006). After that, new regulatory documents have been promulgated to 
standardize the use of medicinal herbs. The National Policy on Phytopharmaceuticals and 
Medicinal Plants in its guidelines, establishes that a list of regional plants is to be defined, 
representing the Regional Popular Phytotherapy (BRAZIL, 2006b). These policies advocate the 
inclusion of the use of medicinal plants in primary health care, which shall be employed with 
highest efficacy and safety and must be object of the actions of Pharmaceutical Services, 
which are also to be applied to manufactured drugs (BARBOSA & PINTO, 2005). 
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The National Policy on Phytopharmaceuticals and Medicinal Plants (BRAZIL, 2006b) has the 
overall objective “to ensure the Brazilian population the safe access and rational use of 
medicinal plants and herbal medicines.” The Pharmaceutical Sciences can contribute 
strongly to this purpose, attending the first specific objective of the document, "expand the 
therapeutic options for users with guaranteed access to medicinal plants, herbal medicines 
and services related to herbal medicine, with safety, efficacy and quality regarding the 
integrality of health care, considering the traditional knowledge about medicinal plants.” 
Achieving this goal requires the combination of elements of Pharmaceutical Sciences such as 
Pharmaceutical Care and Quality Control, with traditional knowledge. 
This concern of the regulatory agency promotes the standardization of herbal medicines 
facilitates the evaluation of important aspects such as efficacy and safety in the use of these 
medications, as the difficulties to standardize the active pharmaceutical ingredient and the 
formulation development of phytomedicines from medicinal plants of popular use represent 
the major challenge in the country. 
Phytomedicines must contain as active ingredients exclusively plant material derivatives. 
The addition of an isolated substance from any source eliminates this characteristic of the 
product. Apart from the methodology chosen for processing  the plant material, one must 
consider the seasonality of its biochemistry, the soil and climate characteristics of its 
growing place or occurrence and the popular and scientific names of the plant (MACIEL, 
2002). Studies show that the secondary metabolism of the plant can vary considerably 
depending on factors such as: seasonality, temperature, water availability, UV radiation, 
nutrients, altitude, air pollution, and even induction by mechanic stimuli or attack by 
pathogens (GOBBO-NETO, 2007). Thus, for developing a phytomedicine it is determining to 
have a well defined plant species, including the unambiguous botanical characterization. 
How to define from which plant species an herbaceous medicine can be developed? 
There are some strategies to reach this definition and here we will discuss about some of 
them which are well known and a new one will be introduced, where therapeutic products 
are directly handled, and which was born within the Pharmaceutical Science. 
The WHO has recommended that member countries, especially the developing ones, shall 
seek to expand their therapeutic arsenal for public health through the use of medical home 
practices employed by the people. These recommendations are summarized in the four 
items mentioned below (MATOS, 2000): 
 Undertake regional surveys of plants used in the practice of people’s or traditional 
medicine and scientifically identify them; 
 Support the use of useful practices selected by their efficacy and safety;  
 Suppress the use of practices considered useless or harmful; 
 Develop governmental programs that allow the cultivation and use of the selected plants. 
The scientific research on medicinal plants generally originates medicines in shoter time, 
often with lower costs and therefore more accessible to the population, which in different 
places on the planet, can’t afford the high costs of medicines used to face the primary needs in 
health care, especially because in most cases the raw materials used in manufacturing these 
products are imported. For these reasons or deficiency of the public primary health care in 
Brazil, about 80% of the population lacks access to essential medicines (TOLEDO et. al., 2003). 
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From a socioeconomic perspective, it is necessary to highlight some aspects such as the 
demand for phytotherapy and the cost of the medicines, the potential for generating 
occupation and income in the phytopharmaceuticals productive arrangement, especially 
under the social economy, the efforts of research that prove, scientifically, the medicinal 
properties of plants, and the need for restructuring the health care system, including the 
preparation of professionals working in this area (NUNES et. al., 2003). 
The recovery and revaluation of the use of medicinal herbs in Brazil today are demanding a 
certain worry since many medicinal plants of high value may disappear from the forests and 
scrub lands, even before scientists can discover their properties, and turn them into 
medicines. The main step that must be taken is to develop techniques for cultivation and 
harvesting without compromising the reproduction of these species. Another measure is to 
prevent urban sprawl from causing the destruction of peripheral green areas which are rich 
in medicinal herbs (ADEODATO et. al., 1996). 
Medicinal plants, which have assessed their therapeutic efficacy and toxicology, or safety of 
use evaluated, among other properties, are scientifically approved to be used by people in 
their basic health needs, according to the ease of access, low cost and compatibility with 
cultural traditions. Since medicinal plants can be classified as natural products safe to use, 
the law allows them to be marketed by notification to the health regulatory agencies 
(BRAZIL, 2010), and they can be cultivated by those who follows agronomical good 
practices. So, the assisted self-medication is practiced in cases of health problems that might 
be considered simpler and more commonplace within a community. This practice tends to 
reduce the demand for health care professionals, rationalising and reducing the cost of 
Public Health Service (LORENZI & MATOS, 2002). 
Despite these recommendations, it seems that the use of medicinal plants in public health 
service is still not a reality in different localities in Brazil and, by extension, in the American 
Continent. This fact can be explained by the lack of scientific data on native species or the 
lack of systematization of the existing data. The lack of political interest signals that this 
issue is not a priority for many governments in different parts of the world. As long as the 
practice of phytotherapy does not bring financial rewards, private capital will not feel 
encouraged to invest in this niche of market, which meanwhile is interested in more 
profitable and less regulated activities. 
1.1 Techniques and methods for selecting medicinal plants 
In the investigation of medicinal plants, a relevant moment, which can set the course of the 
work and its impact on all points of view, is the criterion used for the selection of the plant 
species to study. Cuéllar and Guirado (2008) refer to genomics, metabolomics and 
ecological, botanical taxonomic and epidemiological based studies. On the other hand 
Albuquerque and Hanazaki (2006) point out other ways to study the medicinal plants, 
among which we highlight five basic types of approaches: the randomized, the ethological, 
the chemotaxonomic (also known as phylogenetic or chemosystematic), the ethnodirected 
(or ethno-oriented) and finally, the exploration of promising biological test results 
(ELIZABETSKY; SHANLEY, 1994). 
Some of these options are analyzed below. 
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1.2 The randomized approach  
Several important authors, here mentioned, recognize the randomized approach as an 
approach without criteria. Calderon (2000) and others who worked with forest plots, do not 
identify this form of selecting plants for research, as random. So, the question here to be 
discussed is whether it is a type of random selection criterion or whether it should be 
identified separately as another type of approach? 
The randomized investigations consist in random selection and collection of plant species 
for study, according to the plant availability. When carried out in regions with high 
diversity and endemism the probability of finding novel substances, bioactive or not, is 
certainly higher in this type of selection (MACIEL et al., 2002, OLIVEIRA et al., 2010). It is an 
indispensable approach, once it can demonstrate the potential of different plant species that 
had never been investigated. According to Souza Brito (1996), this type of selection provides 
an endless source of new structures, since nature is a vast chemical laboratory. However, 
there are many mistaken views and criticisms about this approach due to its randomness, 
which does not mean the absence of criteria (ALBUQUERQUE, HANAZAKI, 2006). 
1.3 The ecological approach  
The ecological approach, also known as field observations, consists in observations of 
interactions between organisms in their ecological environment, inducing to potential 
biological activity (antibacterial, antifungal, agrotoxic, pesticide) (GUIRA; CUÉLLAR, 2008). 
This approach searches for secondary metabolites and biological activities and it may be 
performed by the selection of young leaves x mature leaves for a given species, or between 
different species that are shadow resistant and not shadow resistant, among other 
characteristics (COLEY et al., 2003), though little explored, it has achieved excellent results.  
Briskin (2000) states that secondary metabolites present in plant species have ecological 
functions which can justify their use for application in the development of therapeutic 
resources for humans. For example, metabolites involved in plant defense against microbial 
pathogens may be useful as antimicrobial drugs in humans, since they are not very toxic. 
Likewise, secondary products with repellent action (e.g. unpleasant flavor or odour) against 
herbivores by neurotoxic activity could have beneficial effects in humans such as 
antidepressants, sedatives, muscle relaxants or anesthetics, through their action on the CNS. 
Therefore, the observation of these ecological relationships is a useful tool in the selection of 
plant species. 
According to Albuquerque and Hanazaki (2008) this approach intends to evaluate the use of 
secondary metabolites by animals or other non-nutritional substances from plants, aiming to 
combat diseases or controlling them, as it can be seen in the works developed by Carrai 
(2003) and Krief (2004). In the latter, it was observed that leaves of Trichilia rubescens Oliv. 
eaten by chimpanzees in Uganda showed antimalarial activity. This result shows the 
importance of the ethological approach in the discovery of useful plant species of medical 
and pharmaceutical interest. 
A variation of the ecological approach is zoopharmacognosy, also called animal self-
medication (self-medication in animals), which proposes the selection of species regularly 
ingested by animals, especially primates; to reduce microbial infestation, pain (BERRY; 
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MCFERREN; RODRIGUEZ, 1995. In: BIRD; BRIJESH; DASWANI, 2007). To the selection 
criterion based on the observation of the relationship between animals and plants, 
Albuquerque and Hanazaki (2008) attribute the term "ethological approach” based on the 
habits of animals, how they behave in their natural environment. 
1.4 The chemosystematic approach  
When the definition of a plant species, which will be source of a phytomedicine, is based on 
the structural analogy of the substances present in this plant material, with other known 
active substances present in different botanical family, genus or even species, we can infer 
that this strategy is based on chemosystematics, a system created by Professor Otto Richard 
Gottlieb (1982) to organize and understand the plants. This system consists in identifying 
groups of chemicals present in plants, considering the taxonomic organization of these 
plants. To illustrate this topic, consider the use of a plant species containing antiplasmodic 
indol derivatives as active principle in the development of an antimalarial phytomedicine. 
Would a plant species from a different genus, containing such substances, give origin to the 
same phytomedicine?  
Depending on the results the later plant produces in in vitro biological tests, it may be true. 
On the other hand, Mikania species (Asteraceae) which contain coumarin in their 
composition, exhibit different pharmacological activities and alleged popular use, including 
antimalarial properties. Therefore, the strategy based on chemosystematics can bring in it 
some uncertainty, once the chemical composition, which can explain the relationship 
between botanical species, genera and even families, is not decisive enough to guide the 
development of a phytomedicinal product and to validate the alleged use, as well as it does 
not confirm the safety and efficacy of the derivative proposed for the development of the 
product, requiring indeed the realization of a pharmacological prospection in order to 
characterize the wanted activity for the phytomedicine. The contribution of 
chemosystematics is to offer to the phytochemical analyst a range of possible chemical 
structures to be searched in the preparations obtained from the plant material. 
The chemosystematic approach, also called phylogenetic, consists of selecting a species from 
a family or genus, for which some phytochemical knowledge of at least one species of the 
group is known (ALBUQUERQUE, HANAZAKI, 2006). The presence of different 
compounds, which can be used as biosynthetic markers, is used by botanists in taxonomy 
studies and the chemosystematic approach is used as a successful tool in the selection of 
families, subfamilies and genera to be investigated in terms of produced metabolites 
(BASSO et al. 2005). That is, through the chemotaxonomy, one can select plants from known 
families and genera to produce certain classes of substances (e.g. alkaloids, flavonoids, 
steroids, etc.), especially those recognized by their biological activities and therapeutic 
applications, preferably associated to these metabolites. As an example we can cite the case 
of galantamine, used in the treatment of Alzheimer's disease, first isolated from the species 
Galanthus nivalis, Amaryllidaceae family. Since then, numerous chemosystematic studies 
verified the presence of galantamine and acetylcholinesterase inhibitory activity in several 
species of the genus Galanthus (MARSTON; KISSLING; HOSTETTMANN, 2002). Following 
the same line, Ronsted et al. (2008) continued searching for alkaloids with 
acetylcholinesterase inhibitory activity in several species of other genera of Amaryllidaceae 
family, especially Narcisus, obtaining excellent results. 
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Considering that in this case we deal with the selection of plant species for the development 
of herbal medicines or for direct use in primary health care, this feature of the method, 
enabling the discovery of molecules, does not influence the discussion and treatment of the 
theme in this chapter, without, however, making value judgments on this important 
application. Even within the pre-formulation studies carried out during the experimental 
stage of drug development it is an advantage for researchers to know in advance which 
class of metabolites to prospect in order to develop detection, characterization and 
quantification of markers of the active pharmaceutical ingredients and the final product, 
and with these data to establish their quality control process. This step of the process is 
determining for the registration of an herbal medicine in Brazil. 
2. The ethnoguided approach  
The ethnoguided approach consists of selecting plant species in accordance to the indication 
of specific population groups in certain contexts of use, emphasizing the search for the 
locally built knowledge regarding their natural resources and their application in their 
health systems (GUIRA; CUÉLLAR, 2008). Plant species are raised by a quali-quantitative 
survey. This survey usually relates symptoms, signs and diagnosis of low-gravity diseases 
to medicinal plants that the respondents know about and their use according to the cultural 
elements that characterize the ethnicity or human group to which they belong, considering 
the territory as the basis for this characterization.  
In this type of approach the ethnobotany, ethnopharmacology and ethnomedicine can be 
highlighted. Recently ethnopharmacy has been structured to provide an interface between 
Pharmaceutical Science and Popular Phytotherapy where medicinal plant species can be 
selected for the development of phytomedicines and for use in primary health care, in 
compliance with the requirements of safety and efficacy (BARBOSA, 2008). 
Below we schematically present the key steps for developing an herbal medicine 
considering as a starting point the selection of a medicinal plant according to the ethno-
oriented method. Note that the remaining steps of the process do not allow a review of the 
plant identity, once they are irreversible and consume the collected and processed plant 
material, making its selection and identification a crucial step of the process as a whole. In 
Figure 1 below, Material Plant, Crude Extract and Standardized Extract, direct derivatives of 
the medicinal plant, are shown in the purple sequence. The procedures to which these 
materials are subjected are in green and the blue area shows the pharmacological assays. 
Note that both standardized extracts as well as fractions of these extracts can be 
pharmacologically evaluated and taken to the  formulation step where the composition of 
the active pharmaceutical ingredient will determine the pharmaceutical form to be 
developed and the experiments required for this procedure. 
See below a schematic sequence of processes for developing phytomedicine (Fig.1). 
In Brazil, the National Health Surveillance Agency accepts ethno-oriented surveys as the 
basis for the registration of plant species which are used for the development of herbal 
medicines (BRAZIL, 2010) or for use in primary health care (BRAZIL, 2010b). The methods 
applied in these surveys produces plant species lists and information that provide the 
starting point for developing a formulation, when their allegation of use are already 
available. It is also associated with a historical use of the plant, often for a long period, 
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Fig. 1. Schematic sequence of the steps in developing phytomedicines, starting from an 
ethnoguided survey. 
which being documented by scientific literature can contribute to validate its safe use based 
on official resolution. These requirements serve as the basis for the necessary experiments 
for pre-formulation studies. 
2.1 Ethnobotany 
Defining a medicinal plant for developing a phytomedicine under the vision of 
Ethnobotany, a survey of plant species used by a particular human group, certainly ensures 
botanical classification of the plant, since the core activities of Botany is to determine the 
taxa of a botanical sample. Moreover, important information for the production of plant 
material for the development process could also be provided by this approach. However, 
information like remedies preparation, allegations of use, including dosage, and evaluation 
of the remedy use and the relationship between user and derivatives prepared with plant 
material, are not part of the necessary instrumental for the practice of Ethnobotany. 
In order to introduce a discussion on the survey of medicinal plants which are traditionally 
or popularly used for medicinal purposes, and within a historical perspective, this is what 
the Ethnobotany is about, a term coined by Harschberger and, which according to Schultes, 
pointed out ways that could serve to the scientific research (SCHULTE, 1962). Amorozo & 
Gely (1988) complement that ethnobotany, when applied to medicinal plants, acts in 
complicity with ethnopharmacology and medical anthropology, as it contextualizes the use 
of these plants in a treatment system peculiar to a specific human group.  
According to Heinrich and Bremner (2006), the ethnobotany investigates the relationship 
between humans and plants in all its complexity, and is usually based on a detailed 
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observation and study of the plants used by a society, including all its cultural beliefs and 
practices associated with that use. For such research, the ethnobotanists use a complex set of 
methods derived from the social and cultural sciences, including the taking of detailed field 
notes and the carefully documented collection of plant samples that allow a precise 
determination of the corresponding species.  
Regarding the ethnobotanical approach method, Elisabetsky (1987) and De La Cruz Mota 
(1997) advocate the devolution or the return of prepared data to the communities and 
Martin (1986), supports the inclusion of the communities in the research so that the constant 
ethnobotanical making will promote the development and preservation of plant resources, 
knowledge of nature, the restoration of ecological balance with improved life quality. One 
must still think about the profits arising from the business performance of the technological 
development, which starts with the study of the ethnobotanical knowledge, whether in form 
of royalties or compensation to the communities participating in the research. 
2.2 Ethnopharmacology  
The relationship with the environment makes different human cultures absorb a wide 
variety of customs and knowledge from this environment in which they live. This 
knowledge evolves and over time is incorporated into the patterns of each population group 
across generations. The most representative and discussed case at a global level is the use of 
natural products arising from the knowledge of traditional peoples as Indians or riverbank 
people. In this case, a greater attention is given to those people who live in tropical regions 
where the natural range of options is presented in higher proportions, as in the Brazilian 
Amazon (PINTO & MADURO, 2003). 
The most accepted definition of Ethnopharmacology is "multidisciplinary scientific 
exploration of biologically active agents traditionally employed or observed by man" 
(SOUZA et al. 2004). Another useful definition was proposed by Dos Santos & Fleurentin 
(1990) as an "interdisciplinary scientific study of materials from animal, vegetable or mineral 
origin and related knowledge and practices that different cultures use to modify the state of 
a living organism by therapeutic (curative/prophylactic) or diagnostic purposes". According 
to Bourdy (2008), many ethnopharmacological studies seek to correlate pharmacological 
activities found in a traditional remedy with active pharmaceutical ingredients through 
natural products chemistry. Ethnopharmacology, therefore, in its interdisciplinary nature, 
attempts to associate at least three points of view, a cultural, a biological and a chemical 
ones in a complementary approach. 
The Ethnopharmacology seeks to know the illnesses that lead particular human groups to 
practice Herbalism; it discusses symptoms and signs, as well as, experimentally, applies 
pharmacological models to elucidate the action mechanism of phytoderivatives. This 
information is also very important for the development of herbal medicines, but the 
evaluation of the original form of use is decisive for the elaboration of the 
phytopharmaceutical formulation, moreover, it allows the use of medicinal plant in natura 
or in magistral or officinal formulations, after pharmaceutical manipulation in pharmacies. 
The ethnopharmacological method combines the study of popular knowledge with chemical 
and pharmacological techniques. Allegations of popular therapeutic use of a particular plant 
www.intechopen.com
 
Selecting Medicinal Plants for Development of Phytomedicine and Use in Primary Health Care 
 
11 
species are important for the investigation of its pharmacological and toxicological effects 
(ELISABETSKY, 2003). 
Albuquerque and Hanazaki (2006) claim that the ethnopharmacological approach is the 
study of traditional preparations used in health systems and disease, which include, isolated 
or combined, plants, animals, fungi or minerals. According to Maciel et al. (2002), on this 
approach the selection of species is carried out according to the therapeutic use evidenced 
by a particular ethnic group and it most likely favors the discovery of bioactive substances, 
the development of herbal medicines and the introduction of medicinal plants in primary 
health care. Many studies based on ethnopharmacological approach, report results that 
range from strictly botanical information, such as plant taxonomy, to general information 
such as part of the plant used and alleged use (UBOM, 2010; GIUSTI & PTERONI , 2009; 
IGNACIMUTHU et al ., 2006; GIDAY,. 2001). 
Ethnopharmacological strategies have been widely used to conduct biological screening in 
various therapeutic areas such as cancer, immunomodulatory drugs, allergy drugs, 
analgesics, contraceptives, antimalarial, anti-diarrhea, antimicrobial, antiviral, etc. 
(ELIZABETSKY; SHANLEY , 1994). 
Ethnopharmacology, an important methodology for the study of plants used in folk 
medicine, is characterized as a strategy for the investigation of medicinal plants that 
combines information acquired from users of medicinal plants with chemical and 
pharmacological studies. This method, still according to Elisabetsky, allows the formulation 
of hypotheses about the pharmacological activity and the compound responsible for the 
reported therapeutic action. Elisabetsky says "Ethnopharmacology is not about 
superstitions, but of popular knowledge related to traditional medicine systems" 
(ELISABETSKY, 2003). 
2.3 The ethnomedical approach  
The Ethnomedicine refers to the study of diseases, their causes and therapeutic measures 
taken by the various societies of primitive peoples as well as by popular social communities. 
It deals with natural and ancient therapies used to combat diseases and emphasizes the 
relationship between the patient and caregiver, between the patient and society. 
Ethnomedical studies contribute to the knowledge of the techniques used by many ancient 
peoples with regard to the treatment and knowledge of diseases (BENSON, 1980). 
Since ancient times people treated their body and soul illnesses by asking for help to the 
supernatural. Certain peoples of northern Asia, where the tribal priest was called the 
shaman, used magical means, rites and knowledge of nature to heal health problems, 
associating them, among others, with knowledge about healing plants and connecting with 
their gods. So, they antagonized the disease with the active ingredient of the plant and with 
the ritualistic method, they incited the faith, the confidence in the procedure and in the 
shaman, who, in Brazilian Amazon, is called “pajé” or “benzedor” (shaman healer), 
according to more or less intimacy with the ”enchanted" and the "forest spirits" (MAUES & 
VILLACORTA, 2008). 
A significant part of what today is therapeutically used, started from information obtained 
from traditional communities that use natural products in their practices to survive and 
handle the environment. According to Guirado and Cuellar (2008) the ethnomedical 
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approach consists in investigating the plant species on the basis of traditional use by 
different peoples, providing an interface between modern clinical medicine and folk 
medicine. 
2.4 Ethnopharmacy  
The strategy that can gather more information directly linked to the galenic development of 
a phytotherapeutical formulation is the ethnopharmaceutical approach of medicinal plants. 
Here, the semi-structured interviews script allows assessing, among other, the nosological 
profile of the approached human group and the medicinal plants used to treat the signals 
and symptoms mentioned by the interviewers. The method also evaluates the utilization of 
synthetic and herbal medicine by the group, and proposes the participatory observation of 
the remedies preparation using the most promising plant and finally observes aspects 
related to the plant itself. In this way it is possible to characterize the needs of this human 
group in terms of products which solve most of its health problems, this can be seen as a 
market analysis under the pharmacoeconomics point of view; also under this perspective, it 
is possible to determine the scale of this demand, verifying which synthetic medicines are 
not accessible to users and which herbal remedies they prepare to meet the lack of those 
products which are not distributed by the market (open or State), and also by observing the 
preparation of remedies by the community, a pharmacist can deduce a pharmaceutical form 
for the product under development and discover new procedures, as well as new 
pharmaceutical adjuvant. 
For Heinrich (2001), the Ethnopharmacy is the interdisciplinary science that deals with the 
study of pharmaceutical resources considered in relation to cultural determinants that 
characterize the use of these resources in a particular human group. It involves studies on the 
identification, classification and cognitive categorization of plant material from which the drug 
will be produced (Ethnobiology), preparation of dosage forms (ethnopharmaceutics), 
allegation of the effects associated with the preparation (ethnopharmacology) and socio-
medical aspects implied in these uses (ethnomedicine) (PIERONI et al., 2002).  
Heinrich (2007) returns to the subject stating that ethnopharmacy includes pharmacognosy, 
pharmacology, galenic, and also the pharmaceutical practice and clinical pharmacy, thus 
allowing the utilization of local resources in the primary health care, and therefore it 
provides an interface to the Pharmaceutical Assistance necessary to the implementation of 
Phytotherapy in Primary Health Care. 
The ethnopharmacy was introduced in Brazil in 1995 with the publication of the article 
"Ethnopharmaceutics: an approach to medicinal plants from the perspective of 
Pharmaceutical Sciences" (BARBOSA, SILVA, SOLER, 1996). The inventory of data from a 
group or local community on therapeutic resources shows itself as an adequate tool to 
document important information to design actions in the Pharmaceutical Sciences area, both 
from a technological standpoint as for healthcare, since it allows to obtain information about 
infectious diseases, the appropriate medicinal plants indicated for their treatment and it 
infers the most suitable methods for their preparation and use (PINTO, 2008). 
In Brazil, Ethnopharmacy is defined as an interdisciplinary science that investigates the 
perception and use of traditional remedies, within a human group. It deals with the study of 
pharmaceutical resources considering the relations with the cultural context of its use, or the 
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study of cultural determinants that characterize the uses of these resources in this culture. This 
study involves plant ethnotaxonomy, by which the drug is produced; the preparation of 
popular use form (ethnopharmaceutics); the biological evaluation of the pharmacological 
activity of such preparations (ethnopharmacology); clinic ethnopharmacy; medical 
anthropology or ethnomedicine; pharmacotherapeutic follow up and pharmacosurvaillance.  
As a set of materials and practices used to maintain and restore health within a regional 
cultural context, several papers have been published; Bulus (2003) reported the 
ethnopharmacy of malaria in Nigeria; Pieroni (2005), the therapeutic resources of a 
community rooted in the northern Albanian Alps; he has raised about 70 taxa and 160 
preparations; Thabrew (1991) described three species used as immunomodulators in liver 
disorders, in traditional herbal medicine in Sri Lanka. These papers report surveys 
conducted according to the ethnopharmaceutical methodology. 
The ethnopharmaceutical method was developed by integrating environmental and cultural 
elements, thereby becoming a strategy for preserving the cultural heritage of human groups 
and actions for recovering deforested areas (BARBOSA, 1998). 
Souza (2011) proposes the Ethnopharmacy as a science that permeates across the 
ethnosciences related to medicinal plants, especially regarding their use, articulating it with 
those belonging to the identities and cultural imagery of the focused human groups. 
Ethnopharmaceutical science seeks to understand the use of medicinal plants through the 
social representations of communities based on the oral diffusion of knowledge about the 
community's relationship with the environment, availability of medicinal plants, as these 
representations are keys to the establishment of the safety validation process and rational 
use of medicinal plants 
Thus, we propose two strands to the ethnopharmaceutical methodology: as a science (where 
there is an object, methodology and production of knowledge) and as a social technology 
where it develops products, methods and services together with communities, replicable in 
other communities, aimed in improving their life quality and favoring their social inclusion. 
To illustrate the proposal presented above, we show the figure 2 below that tries to 
characterize the composition and the insertion of Ethnopharmacy in the science and 
technology fields and thereby demonstrate the breadth and scope of its instruments when 
applied in Popular Phytotherapy survey, with the aim of pointing out plant species for 
phytomedicine development and their use in primary health care. 
The ethnopharmaceutical survey is an instrument of the quantitative research advocated by 
the social technology Ethnopharmacy, which brings together a methodology and a 
theoretical basis to leverage the popular herbal medicine as a basis for Pharmaceutical 
Attention in medicinal plants, after processing of the collected data by the Pharmaceutical 
Science. 
The contribution of accessed human groups is significant, as well as the participation of the 
academy and the public sector; the participation of the private productive sector is still 
lacking, which, in Brazil, needs to adequate its action and thought to the national sanitary 
surveillance rules in order to contribute in building this important economic and social 
sector that is the market for herbal medicines. 
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Fig. 2. Representative diagram of the interdisciplinarity of Ethnopharmacy. 
 
Fig. 3. Meeting of researchers in Ethnopharmacy of Para Federal University with members 
of local collectivities, including traditional specialists, discussing the local phytotherapy 
(Igarapé Miri, Para, BR) 
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2.4.1 The ethnopharmaceutical approach and the use of flora  
Different methodologies have taken into account the human and cultural component in their 
survey and approach of plant species with therapeutical popular use. The ethnobotany and 
ethnopharmacology dispute the antiquity: there are still ethnomedicine, the ethnobiology 
and there are others emerging. 
In the development of herbal medicine, ethnobotany and ethnopharmacology play an 
important role towards this approach when aiming the popular information retrieval, the 
empirical knowledge which has been transmitted from generation to generation by shamans 
and healers in all cultures and traditions. The ethno-oriented survey puts the popular 
information as an important reference for the experiments both with regards to the 
exploitation and use of herbal drugs and phytomedicines, as well as for the development of 
new remedies. 
Following this track, the instrumentation of methods and techniques has been established  
in the pursuit of a unique language that features not only recognition but also the 
application of traditional knowledge about plants and/or healing practices. One should also 
take into account the idea that the notion of illness and healing practices are understood 
through cultural references. In this context it is assumed that there are subjective factors 
related to the values and traditions of individuals and cultures that influence the formation 
of symptoms and how to treat them. This is therefore, the track that leads to the concept of 
the ethnopharmaceutical approach, demarcated on its roles and joints to other research 
areas by the objectives (BARBOSA, 1996):  
 To understand the cultural meaning of a given disease and its healing process in a 
given community; 
 To raise the traditional use of plant species in these communities while observing the 
social anthropological view, the inter-relationship of possible medicinal effects, their 
use in food and involved ritual habits as therapeutic tools for treatment of diseases; 
 To recognize the plant species used, their botanical and popular nomenclature; 
 To recognize in the traditional remedy the pharmaceutical form involved in its 
preparation; 
 To prepare, in an interdisciplinary way, a method to exploit the species involving from 
cultivation to marketing; 
 To propose, based on the plant investigation, from the scientific point of view, new 
applications for the species, either through pharmacological, biological and/or suitable 
technological approaches in the Pharmaceutical Sciences field; 
 To standardize the pharmacognostic, phytochemical and pharmacotechnical protocols 
for regulation and quality control in the marketing and use of herbal medicine, among 
others; 
 To produce knowledge from the results obtained during the development and use of 
the investigated medicinal plant. 
The cultural elements of the community, related to fundamental traditional healing practices 
regarding the use of plant species, have been undergoing a process of devaluation, even 
discredit, due to the scrapping of medical care, caused by political and economic reasons. 
Moreover, the easy access to the allopathic medicine, encouraged by official policies of 
distribution of these drugs without proper pharmaceutical care, has led, even in 
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communities with ancient traditions, such as indigenous peoples, a depreciation of the 
traditional healing practices, so that the only alternative that remains to the ordinary 
member of the community is to ingest the industrial drug according to color or flavor, with 
the (dis) orientation of hardworking, but unprepared people for this important task. 
In this context, briefly exposed, because it is matter for reflection in a specific chapter, the 
ethnopharmaceutical approach comes as an element of preservation and appreciation of 
traditional therapeutic practices, since all the experimental work is based on valuable 
information gathered from the plant user. This information is firstly systematized and 
documented, making it possible to provide a memory of the practices and the empirical 
knowledge of people about the plants used therapeutically. 
The empirical statements, allegations of a plant use, refer to symptoms that correspond to a 
pharmacological test model, which can validate the indication of the preparation traditionally 
used obtained according to pharmaceutical techniques properly deduced from the popular 
mode of preparation. These data, together with those obtained from the chemical analysis of 
the plant, will enable to propose a defined therapeutic formulation containing a biologically 
active extract or an active fraction of this extract, ingredient that may be monitored for quality 
because it was chemically analyzed and presents the original activity properly quantified 
(effective dose and "toxic" or lethal dose) indicated by the community. 
Among the information collected from communities, one should consider and seek to interpret 
the apparently unimportant data related to the symptoms described, to the collection of plant 
material, to the preparation of the medicine and to the usage of this drug. These data may be 
critical to the success of the experimental work. Details concerning these apparently mystical 
aspects of the plant use may indicate some procedures to be followed when preparing the 
material for testing and analysis, so it should not be seen merely as superstition. 
2.4.2 Data produced from selected species according to the ethnopharmaceutical 
method  
An ethnopharmaceutical survey conducted in 2008 in the State of Pará, Amazonia, Brazil 
showed that an Iridaceae (marupazinho) was indicated to treat diarrhoea, anaemia and 
abdominal pain. 
 







High blood pressure Garlic 67%
Gastritis Pirarucu 50%
Fever Catinga de Mulata 42%
Source: from Pinto, 2008, (yet unpublished data). 
Table 1. The alleged medicinal uses of plants according to the relative frequency of alleged 
use (RFAU) calculated according to Amorozo & Gely (1988). 
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Combining these symptoms and adding information obtained from a traditional specialist 
we can infer that this plant could be used to treat amoebiasis (yet unpublished data). Indeed, 
in the Amazon region this plant is an important therapeutic option, used in primary health 
care. Jardim et al (2007) had demonstrated the use of a tea from the bulbs of this plant in the 
popular phytotherapy, to treat diarrhoea. The here mentioned ethnopharmaceutical survey 
discloses a convergence of popular use (AMOROSO; GELY, 1988) of about 80% for 
diarrhoea (Table 2), which rises to about 100% when other symptoms of amoebiasis are 
associated. These surveys were carried out in different cities of the state of Pará. Additional 
phytochemical and galenic studies were performed and a formulation will soon be 
developed; furthermore, the data already obtained can indicate the plant to be accepted as a 
medicinal plant of interest to the Brazilian primary health care system (BRASIL, 2010). 
An ethnopharmaceutical approach started a multidisciplinary study on a Piperaceae and an 
Euphorbiaceae and enabled the development of formulations to control arterial 
hypertension and to treat bacterial skin affections, whose patenting processes are in course. 
A Bignoniaceae mentioned by virtually all respondents, more than 1,200 people (Table 1), as 
having anti-anaemic activity, also shows important antifungal activity on skin affections 
(BARBOSA, 2008) among others. After the extract administration in animals, the 
haematological parameters were evaluated in their collected blood samples. The extract did 
not affect the following parameters: leukocytes, red blood cells, haematocrit, haemoglobin, 
MCV, MCH and MCHC, however, a significant increase in platelet counts for the 
experimental group could be observed, what can indicate that the aqueous extract 
stimulates the production of platelets (yet unpublished data) (Table 2). 
 
Haematimetric Index Control group n=20 Experimental group n=20 P* value 
Haemocyte (/mm3) 5.7±1.6 6.2±0.9 0.6423 
Haematocrit (%) 41.3±9.2 41.5±3.7 0.4525 
Haemoglobin (g/dL) 13.8±2.7 13.7±1.1 0.4275 
MCV (fL) 50.2±2.7 51.6±1.9 0.1555 
MCH (pgL) 16.5±0.7 16.9±0.7 0.2164 
MCHC (g/dL) 33.1±1.2 33.09±1.6 0.9427 
Platelets (mm3) 702±244 888±201 0.0498 
Table 2. Haematimetric indices and platelet counts of animals exposed to plant extract and 
the control group. Hematologic parameters of control group are similar to other studies in 
which the same strain of mice was used, and corroborate the study by Pessoa et al. (2008) 
that observed the lack of significance between hematological parameters of Rattus norvegicus 
treated with plant extract. 
The approximation of ethnopharmacy with pharmaceutical care provided the establishment 
of a new attribution to the ethnopharmaceutical method, namely: the selection of popular 
medicinal herbs for introduction in primary health care. Eleuthrine plicata (BRAZIL, 2009), 
Arrabidea chica (BRAZIL, 2011) and Zingiber officinalis (BRAZIL, 2010B), are species listed in 
official documents that have been related in ethnopharmaceutical surveys conducted in 
different localities in the Amazonian state of Pará. 
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3. Comparison between the randomized and ethnoguided approach  
It is expected that the traditional knowledge about medicinal plants indicates the presence 
of biologically active substances. The collection of plants traditionally used for biological 
assessment can be a great advantage, or a shortcut, increasing the chances of discovering 
new drugs (ELIZABETSKY & SHANLEY, 1994). Table 3 shows the enormous potential of 
the ethnopharmacological approach found in several studies, compared with the 
randomized approach. 
Some studies have compared the results obtained by the random selection of plants with the 
ethnopharmacological approach, also called ethnoguided approach. In Rwanda, Africa, 100 
medicinal plants were tested for antimicrobial activity. From these, 68 were referred for 
infectious diseases, 37% of which were active, whereas for the 36 medicinal plants that were 
included by the random approach only 22% showed activity (VAN PUYVELDE & BOILY, 
1986). In another study conducted at Sinai (Egypt) for plants with antimicrobial activity, 
83.3% of the species obtained positive results by the ethnoguided approach against 41.7% in 
the randomized approach (KHAFAGI & DEWED, 2000). In Brazil, a study of antimalarial 
activity performed with extracts from 295 plant species, 273 were tested by a randomized 
approach with only 0.7% of positive results, whereas for the 22 medicinal plants with 
indications for fever and malaria the positive results represented a total of 18% 
(CARVALHO & KRETTLI, 1991). In Belize, Central America, random collections of plants 
sent to the National Cancer Institute (NCI, USA) for anti-HIV activity resulted in 6% of 
active samples. However, with ethnopharmacologically selected samples, from a healer in a 
small village in Belize, an activity of 25% was obtained, showing a percentage four times 
higher (GUIRA & CUELLAR, 2008). 
 
BIOLOGICAL ACTIVITIES RANDOM (%) ETHNO (%) 
Antineoplasic 6 25 
Antihypertensive 31 44 
Anthelmintica 9.8 29.3 
Ichthyotoxicity 9.6 38.6 
Toxic/venoms 10.5 52.2 
Anti-HIV 8.5 71.4 
Antimicrobial 22 37 
Antiplasmodial 0.7 18 
Acetylcholinesterase inhibition 8 42.3 
Source: from Oliveira et al. 
Table 3. Comparison between the numbers of hits achieved by Ethnopharmacological x 
Random approaches in the search for different biological activities (OLIVEIRA et al. 2011). 
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Slish and colleagues (1999), when evaluating plant extracts obtained by the ethnoguided 
method (n = 31) for the relaxation effect in rat aortic smooth muscle, had a score of 12.9% 
active species, whereas by the random approach (n =32) no active species were observed. In 
an assessment with 80 traditional medicine plants from Reunion Islands for angiotensin-
converting enzyme inhibitory activity, which plays an important role in blood pressure 
regulation and diuresis, 44% of the species indicated by their antihypertensive or diuretic 
effect were active against 31% of the species without such indications (ADSERSEN & 
ADSERSEN, 1997). 
The selection of plants for use in primary health care should be based on the nosology of the 
region, referred to in the Brazilian Policy for Phytomedicine and Medicinal Plants (BRAZIL, 
2006), which is determined by an interview survey conducted among local experts in the 
communities . The nosological map obtained, defines the range of plants that are then 
selected according to technical criteria, considering their agronomic and pharmaceutical 
aspects. The list of the plants used to treat diseases that compose the nosological profile 
emerges from the treatment of the information provided by the respondents, applying the 
programming rule of the Pharmaceutical Assistance (BARBOSA, 2008). 
4. Possible innovations in phytomedicine development from the ethnoguided 
surveys  
The development of herbal medicines, as they need to generate specific parameters for each 
formulation, is more productive in terms of knowledge than in terms of the synthetic 
analogue, once the constitution of each species that gives rise to herbal medicines varies 
from one species to another. Compatibility studies of adjuvant in relation to the components 
of plant extracts, the need to characterize quality markers, pharmacologically active or not, 
all this set induces a creative process marked by strong innovative character. Some topics 
are presented below: 
 Regulation of pre-products and insumes; in the legal-administrative sphere, the 
phytomedicines bring and impose the need to develop regulatory frameworks that do 
not exist in many countries. 
 Documentation of traditional knowledge in the form of a regionalized National Plant 
Pharmacopoeia; in continental countries like Brazil, or which have microclimates with 
different biomes, this is a remarkable feature, and the existence of national human groups 
with appropriate cultural heritage, possessing their own herbal knowledge also influences. 
 Development of products to attend the national nosology; as a result of the ethno-
oriented surveys which, besides the list of plants can generate a regionalized 
nosological profile; this profile guides the development of therapeutical formulations to 
treat local diseases, often neglected by large laboratories . 
 Using the production of medicinal plants to recover degraded areas; to meet the national 
and local demands for plant material both for herbal medicines production as for use in 
primary health care, it is necessary to cultivate selected species, which can be intercropped 
and would not make sense to grow them in forested areas, but in areas that could be 
recovered.   
 Involving the communities in the production projects; since it is an ethno-oriented 
process, it involves communities per se; in the case of Ethnopharmacy, a social technology, 
the involvement of organized human groups is higher and can trigger initiatives. 
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 Applying new methods for development; the partnership of the academy in the 
development of phytomedicines, required due to the low participation of the 
pharmaceutical productive sector in this process, induces the application of modern 
techniques, as the academy, apart from contributing to the process still needs to 
produce knowledge in accordance to the regulatory sector. 
5. Medicinal plants in the basic health care from ethnoguided approach 
In Brazil the traditional use of medicinal plants was recognized by the public health 
administration and was integrated into the official health system through the National 
Policy of Complementary and Integrative Practices (BRASIL, 2006b). 
To support this therapeutical option available to the general population that uses the 
Integrated Brazilian Health System (SUS), regulatory documents were elaborated and 
promulgated which present a list of medicinal plant species of popular or traditional use, 
selected on basis of a set of information that indicates and supports the alleged use of these 
plants, its form of use and the cares to be taken in the preparation and the administration of 
the therapeutical product. 
The information that substantiates the inclusion of a given medicinal plant species into the 
primary health care is carefully conferred in the scientific literature. Data on botanical, 
agronomical, pharmacognostic and chemical characteristics are checked for the unequivocal 
description of the plant material to be considered as a potential source for an officialised 
phytotherapeutical. Results concerning the effectiveness and security of the herbal drug or 
its derivatives as well as information about toxicological, pre-clinical and clinical investigation 
of the plant species, herbal drug or preparations obtained from them,  complete the set of data. 
So, in this way, medicinal plant species are inserted into the list of phytotherapeutical for use 
in the basic health attention. Nowadays vegetal species and derivatives species are available 
as therapeutic resource in the basic pharmaceutical assistance program. 
Since information about a given medicinal plant species is still to be produced, the plant is 
inserted in the national Relation of Medicinal Plants of Interest for the Integrated Brazilian 
Health System (RENISUS), where the medicinal plants species that present good potential to 
generate products of interest to the SUS, or plant species that can be incorporated into the 
Live Pharmacies (an official program of medicinal herbal gardens cultivated in units of basic 
health assistance) or generate phytotherapeutical (teas, tinctures, pomades or other simple 
pharmaceutical forms) are inserted. 
The purpose of this list is to guide studies and research that can support the elaboration of a 
relation of available phytotherapeuticals for safe and effective use by the population, to treat 
some mild illnesses. Currently, “espinheira santa”and “guaco”phytotherapeutic derivatives 
are offered, respectively, for gastritis and ulcer, and for cough and influenza (BRAZIL, 
2009). 
In RENISUS there are 71 medicinal plant species with therapeutical potential to induce the 
development of research projects and to motivate organization of productive arrangements; 
which are disclosed by the National Programme of Medicinal Plants and Phytomedicines of 
the Health Ministry. Amongst these medicinal plant species Cynara scolymus (artichoke), 
Schinus terebenthifolius (aroeira da praia) and Uncaria tomentosa (cats claw) can be found, 
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which are used, according to the popular knowledge, to treat digestive disorder, vaginal 
inflammation and articulation pains, respectively, and whose indications are scientifically 
confirmed (BRAZIL, 2009). 
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